Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/04/2857996/0/en/Lirum-Therapeutics-to-Present-Positive-Data-on-LX-101-a-Novel-Clinical-Stage-Targeted-Therapy-Demonstrating-Potent-Preclinical-Activity-Against-Adult-and-Pediatric-IGF-Related-Canc.html
https://www.globenewswire.com//news-release/2024/03/14/2846225/0/en/Lirum-Therapeutics-Announces-Positive-Data-on-LX-101-a-Novel-Clinical-Stage-Targeted-Therapy-Demonstrating-Potent-Preclinical-Activity-Against-IGF-Related-Cancers-Accepted-for-Pres.html
https://www.globenewswire.com//news-release/2024/02/26/2835098/0/en/Lirum-Therapeutics-Presents-Positive-Data-on-LX-101-a-Novel-Clinical-Stage-Targeted-Therapy-at-the-2024-ESMO-Targeted-Anticancer-Therapies-Congress-Highlighting-LX-101-s-Potential-.html
https://www.globenewswire.com//news-release/2024/01/09/2806683/0/en/Lirum-Therapeutics-Participates-in-the-13th-Annual-LifeSci-Partners-Corporate-Access-Event.html
https://www.globenewswire.com//news-release/2023/10/31/2770562/0/en/Lirum-Therapeutics-Presents-Positive-Data-on-LX-101-a-Novel-Clinical-Stage-Targeted-Therapy-Demonstrating-Potent-Preclinical-Activity-Against-Pediatric-Sarcomas.html
https://www.globenewswire.com//news-release/2023/10/19/2763134/0/en/Lirum-Therapeutics-to-Present-at-the-2023-ThinkEquity-Conference.html
https://www.globenewswire.com/news-release/2023/06/05/2682300/0/en/Lirum-Therapeutics-Presents-Data-on-LX-101-a-Novel-Clinical-Stage-Targeted-Therapy-Demonstrating-Potent-Preclinical-Activity-Against-a-Range-of-Pediatric-Cancers.html